Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy
Status:
Completed
Trial end date:
2017-04-04
Target enrollment:
Participant gender:
Summary
This registry will remain open for approximately 5 years (4 years of enrollment + 1 year of
follow up). Subjects will be followed until Orthotopic Liver Transplant (OLT), resolution of
liver decompensation, death, or conclusion of the registry.